Is HBsAg loss an ideal end-point of oral antiviral therapy in chronic hepatitis B patients?

Keunhee Kang, Ji H.oon Kim

    Research output: Contribution to journal › Comment/debate › peer-review

    Fingerprint

    Dive into the research topics of 'Is HBsAg loss an ideal end-point of oral antiviral therapy in chronic hepatitis B patients?'. Together they form a unique fingerprint.